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Effects of dialysate acidity on ultrafiltration
INTRODUCTION
The short and medium term efficacy of peritoneal dialysis
(PD) is well documented (1). However, more and more
studies have pointed out the concern of the efficacy of
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ABSTRACT
The effects of pH of conventional lactate-based peritoneal dialysis solutions (LPDS) on the net
ultrafiltration and solute removal in intermittent peritoneal dialysis (IPD) were studied. Conventional
LPDS is rendered acidic to minimize the caramelization of glucose. Fifteen stable uremic patients
were put on weekly IPD with a conventional 1.5% LPDS (hourly 2 L cycle for 60 L). pH of the LPDS
was raised to around 7.4 by the addition of 1.4 mmol sodium hydroxide (1 M solution) to each litre
of LPDS under an aseptic condition before the commencement of dialysis. A similar study was
performed with the same 15 patients but the sodium hydroxide was replaced by a similar amount
of sodium chloride. The net ultrafiltration, removal of urea, creatinine, sodium, and potassium
were determined and compared. Serum levels of urea, creatinine, sodium, and potassium were
also measured before and after the IPD. No peritonitis was encountered during the study. The net
ultrafiltration volume in the euvolemic LPDS group was greater than the acidic LPDS group although
this was not statistically significant [(mean ±SD) 2526 ±910 mL and 2186 ±750 mL, respectively, p
= 0.21]. The clearances of urea, creatinine, sodium, and potassium showed no differences in both
groups. We concluded that the ultrafiltration, clearances of urea, creatinine, sodium, and potassium
in IPD were not affected by the pH of a LPDS from our results and a larger study is warranted to
see the effect of dialysate pH on the peritoneal membrane.
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PD in the long-run. Two most often causes of the
treatment failure of PD are peritoneal infection and
peritoneal membrane function failure, especially the
ultrafiltration failure (2). Heimburger et al reported that
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26 oC) and the net ultrafiltration volume, sodium,
potassium, urea and creatinine levels of the spent
dialysate were also determined. The study was then
repeated in the same 15 patients 1 week later but the
sodium hydroxide solution was replaced with a similar
amount of sodium chloride solution in order to keep the
osmolarity of the dialysate similar to the previous study.
Results were expressed as mean ±SD. Statistical
significance was measured by the paired student's t test
with p < 0.05 taken to be significant.
RESULTS
Fifteen patients (6 male, 9 female) were recruited for
the study. The mean age was 61.6 ±9.6 years old. No
peritonitis was encountered during the study.
Results of the blood and spent dialysate chemistry are
depicted in table 1. There was no significant difference
in the blood chemistry, ultrafiltration volume, spent
dialysate sodium, potassium, urea and creatinine
concentration between the conventional LPDS and the
"neutralized" LPDS.
DISCUSSION
The acidic pH of the conventional LPDS has been shown
to be "bioincompatible" to human cells and has a
detrimental effect on many cellular functions (5). It is
shown that many of these cellular dysfunctions can be
improved by neutralization of the LPDS (7) or the use
of a bicarbonate-based PD solution (5).
Sodium bicarbonate (8.4% solution) has been used
successfully for neutralization of the LPDS (8). However,
a relatively large amount of sodium bicarbonate is needed
to raise the pH of LPDS from 5.2 to 7.4. Since the
peritoneal membrane removes water from blood more
freely than sodium (sodium sieving) (9), the higher
sodium concentration of the dialysate after the titration
may cause hypernatremia and sodium retention in
patients on PD. Sodium hydroxide is a stronger base than
sodium bicarbonate and has been used for the
neutralization of the LPDS (4). However, caution has to
be taken against over-titration.
In CAPD patients, there is a residual peritoneal volume
amounted to 200 mL. Any freshly instilled conventional,
acidic LPDS will be neutralized to a more physiological
pH in around 15 to 30 minutes (10). In a CAPD patient
on 4-exchanges of peritoneal dialysate per day, the
peritoneal membrane will probably be exposed to an
acidic environment for just around 1 to 2 hours per day.
In our study, in an attempt to maximize the possible
effects of pH of LPDS on the peritoneal membrane
ultrafiltration failure could be found in up to 30% of
patients who had been put on continuous ambulatory
peritoneal dialysis (CAPD) for more than 6 years (3).
Extensive studies have been conducted to identify the
risk factors associated with treatment failure.
Bioincompatibility of the PD solution may be one of the
causes of peritoneal membrane failure. Various
components of PD solution have been identified as
"bioincompatible" to human peritoneal membrane. These
bioincompatible components may include the high
osmolality, low pH and unphysiologically high glucose
and lactate concentration. On prolonged exposure to such
a hostile milieu, the function of the peritoneal membrane
will be affected.
Conventional lactate-based peritoneal dialysis solution
(LPDS) is rendered acidic, pH in the realm of 5.2, to
minimize caramelization of glucose and the spontaneous
c h e m i c a l  t r a n s f o r m a t i o n  o f  g l u c o s e  t o  5 -
hydroxymethyfurfural and its acidic metabolites during
autoclaving. The titrable acidity is approximately 1.5 mM
(4). This pH is unphysiological to human body and has
been shown to be associated with a variety of cellular
dysfunction (5) and ultrafiltration failure (6). In an
attempt to determine the effects of peritoneal dialysate
acidity on the function of peritoneal membrane, we
compared the ultrafiltration volume and the clearances
of various solute molecules of "neutralized" LPDS to
that of conventional acidic LPDS in patients on
intermittent peritoneal dialysis (IPD).
METHODS
Fifteen stable end-stage renal failure patients on weekly
IPD were recruited for the study after informed consent.
Sixty L of conventional 1.5% dextrose LPDS (Dianeal ®,
Baxter Healthcare Corp., Deerfield, IL) was delivered
by an 2 L hourly cycle using an automatic cycler with an
in-flow time, out-flow time, and dwell-time of 15
minutes, 15 minutes and 30 minutes, respectively. pH
value of the LPDS was adjusted to 7.4 by adding 7 mmol
of a sterile sodium hydroxide solution (1 M) to each of
the 5 L bag of LPDS (1.4 mmol/L) under an aseptic
condition into the injection port and then mixed well with
the dialysate. The titrable acidity of LPDS is typically in
the range of 1 mM to 2 mM (4). pH of the "neutralized"
LPDS was measured before the commencement of the
IPD to prevent over-titration. Serum urea, creatinine,
sodium, potassium, and bicarbonate levels were
determined before and after the IPD. Blood sugar level
was also monitored by hemoglucostix during each
intermittent dialysis (IPD) session to ensure no
hyperglycemia during the treatment. All the spent
dialysate was collected at room temperature (around
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transport characteristics, we recruited patients on IPD
with hourly exchange of dialysate. The peritoneal
membrane would be bathed in an acidic environment
for a greater proportion of time during IPD using
conventional LPDS.
Yamamoto et al (8) reported that ultrafiltration volume
increased significantly during the trial of neutralized
LPDS (using sodium bicarbonate to neutralize the
LPDS) when compared to conventional LPDS in CAPD.
It has been observed that low pH of the peritoneal
d i a ly sa t e ,  e spec i a l l y  i n  combina t ion  wi th
hyperosmolality and high lactate concentrations, would
cause vasodilatation and recruitment of more capillaries
in the peritoneal microvascular beds (11). Therefore, the
conventional, acidic LPDS would cause a more rapid
loss of glucose gradient than the neutral solution because
of an increase in "effective" vascular surface area for
exchange early during the dwells (6). A neutral solution
would have a better ultrafiltration effect because the
glucose osmotic gradient will be better preserved over
time with neutral solutions. However, due to the use of
sodium bicarbonate in the neutralization of the LPDS
in their study, the osmolality of the "neutralized" LPDS
is higher than that of the conventional LPDS. Therefore,
the increase in the ultrafiltration volume cannot be
attributed to a more physiological pH of the "neutralized"
peritoneal dialysate alone.
In our patients, in order to study the effect of the dialysate
acidity on the peritoneal membrane transport
characteristics without any confounding factors, the
osmolality of the "neutralized" and conventional LPDS
is similar before the IPD. Rippe et al reported the
theoretical behavior of PD solutions having low versus
neutral pH (6). From the computer-simulated glucose
concentration as a function of time in the neutral PD
solutions, it was found that the glucose concentration in
neutral PD solutions was always higher than that for the
acidic (conventional) solutions. They demonstrated the
presence of a more favorable ultrafiltration profile for
neutral PD solutions compared to acidic solutions. The
difference in ultrafiltration volume after 4 hours between
acidic and neutral solutions would theoretically be of
the order of 100 mL. Given the usually large
interindividual variability in drained volumes, such a
difference may, however, be hard to detect clinically in
a small-scale study. Thus, in the present study, we failed
to demonstrate this difference. Our result suggested that
although there was a tendency toward an increase in
ultrafiltration volume with the use of "neutralized" LPDS
when compared to conventional LPDS, the difference
did not reach statistically significant level (p = 0.21).
We concluded that the peritoneal dialysate acidity may
affect the transport characteristics of the peritoneal
membrane in IPD though the effects were not statistically
significant. Further studies are warranted to study the
long-term effects of the dialysate pH on the peritoneal
membrane as a first step toward the study of a
biocompatible PD solution.
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